Stockscreener 앱 받기
1.16
4.92%
-0.06
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
MIRA completes Phase 1 trial of oral NMDA drug Ketamir-2 - Investing.com
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2 - Corsicana Daily Sun
MIRA tests oral Ketamir-2 for chemo nerve pain after safe Phase 1 - Stock Titan
MIRA Pharmaceuticals, Inc. (MIRA) Competitors - Meyka
MIRA Completes Phase 1 Trial of Ketamir-2 Therapy - TipRanks
Mira Pharmaceuticals Inc completes phase 1 dosing of Ketamir-2SEC filing - marketscreener.com
Mira Pharmaceuticals IncCompletes Phase 1 Dosing Of Ketamir-2SEC Filing - TradingView
MIRA Pharmaceuticals (NASDAQ: MIRA) finishes Ketamir-2 Phase 1 dosing with encouraging safety - Stock Titan
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 29.4% in February - MarketBeat
Ideas Watch: How does MIRA Pharmaceuticals Inc compare to its peersPortfolio Risk Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Risk Analysis: What is the Moat Score of MIRA Pharmaceuticals IncWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn
MIRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Summary: What are MIRA Pharmaceuticals Incs recent SEC filings showingJuly 2025 Opening Moves & Safe Capital Investment Plans - baoquankhu1.vn
MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M - MSN
What is MIRA Pharmaceuticals Inc. s revenue forecastEarnings Overview Report & Daily Price Action Insights - mfd.ru
MIRA PE Ratio & Valuation, Is MIRA Overvalued - Intellectia AI
What are MIRA Pharmaceuticals Inc.’s recent SEC filings showingPortfolio Value Summary & High Conviction Buy Zone Alerts - mfd.ru
How does MIRA Pharmaceuticals Inc. compare to its peersJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - mfd.ru
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6%Time to Sell? - MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6%Time to Sell? - MarketBeat
Bear Alert: How is GIGGW managing supply chain issues2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 - Investing.com Nigeria
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study - Rutland Herald
Cancer nerve pain has no approved drugs. Oral trial nears first-phase finish - Stock Titan
MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort - TipRanks
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Pensacola News Journal
Value Recap: What is the Moat Score of MIRA Pharmaceuticals IncWeekly Trade Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Can MIRA Pharmaceuticals Inc. stock deliver consistent earnings growthGlobal Markets & Safe Entry Zone Identification - bollywoodhelpline.com
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest - Defense World
Nasdaq Moves: Is DiaMedica Therapeutics Inc a cyclical or defensive stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Aug Big Picture: How does MIRA Pharmaceuticals Inc compare to its peersGap Down & Detailed Earnings Play Strategies - baoquankhu1.vn
Will MIRA Pharmaceuticals Inc. stock maintain dividend yieldWide Width Options & HOKA model picks for your routine - Улправда
Trendlines Suggest Garment Mantra Lifestyle Limited May Bottom Out Soon - Bollywood Helpline
2026 world cup usa national team qualification midfield leaders build up play winner prediction guideJuly 2025 Volume & Low Volatility Stock Recommendations - Улправда
2026 world cup mexico qualification playmakers low block knockout prediction analysis - Улправда
2026 world cup canada qualification match preview insightsIndex Update & Fast Entry and Exit Trade Plans - Улправда
Quarterly Risk: Will MIRA Pharmaceuticals Inc stock gain from strong economyJobs Report & Real-Time Buy Signal Alerts - Bộ Nội Vụ
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update - MarketBeat
Resistance Break Could Fuel Unichem Laboratories Limited RallyEarnings Beat Highlights & Maximize Gains Professionally - Bollywood Helpline
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus By Investing.com - Investing.com South Africa
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus - Investing.com
Will MIRA Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Recap & Fast Moving Stock Trade Plans - Bölüm Sonu Canavarı
Is MIRA Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
MIRA Pharmaceuticals (MIRA) details 2025 CEO bonuses and equity awards - Stock Titan
Can MIRA Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Setup with ROI Potential - Улправда
Is MIRA Pharmaceuticals Inc. stock attractive for growth ETFsMarket Performance Recap & Technical Pattern Alert System - Улправда
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1% – Here’s What Happened - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1%Here's What Happened - MarketBeat
0.77%
0.29%
자본화:
|
볼륨(24시간):